• 1. Feasibility of polyethylene composites reinforced by distillers dried fibers with solubles (DDFS) after different generations of ethanol fermentation?
  Bo Chen,Xiaotong Shen,Zhangfeng Luo,Di Cai,Changjing Chen,Changwei Zhang,Peiyong Qin,Hui Cao,Tianwei Tan RSC Adv., 2018,8, 25602-25610
• 2. Expanding nanoparticle multifunctionality: size-selected cargo release and multiple logic operations?
  Danlei Xiang Nanoscale, 2021,13, 5497-5506
• 3. Fe3O4/Au/Fe3O4 nanoflowers exhibiting tunable saturation magnetization and enhanced bioconjugation
  Feng Shi,Kunping Yan,Mingli Peng,Xiao Cheng,Yanling Luo,Xuemei Chen,V. A. L. Roy,Zuankai Wang Nanoscale, 2012,4, 747-751
• 4. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides Aromatic anilides

Recent Advances in the Study of N-(4-Amino-5-chloro-2-hydroxyphenyl)-3,4-dichlorobenzamide (CAS: 95709-82-3)

The compound N-(4-Amino-5-chloro-2-hydroxyphenyl)-3,4-dichlorobenzamide (CAS: 95709-82-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features and potential pharmacological properties, is being investigated for its applications in drug development and therapeutic interventions. Recent studies have focused on elucidating its mechanism of action, optimizing its synthesis, and exploring its biological activities.

One of the key areas of research involves the compound's potential as a modulator of specific biological pathways. Preliminary findings suggest that N-(4-Amino-5-chloro-2-hydroxyphenyl)-3,4-dichlorobenzamide may interact with certain enzyme systems, leading to inhibitory or activating effects that could be harnessed for therapeutic purposes. Researchers have employed advanced computational modeling and high-throughput screening techniques to identify its molecular targets and predict its binding affinities.

In terms of synthetic chemistry, recent efforts have been directed toward improving the yield and purity of N-(4-Amino-5-chloro-2-hydroxyphenyl)-3,4-dichlorobenzamide. Novel synthetic routes have been proposed, leveraging green chemistry principles to minimize environmental impact while maintaining high efficiency. These advancements are critical for scaling up production and ensuring the compound's availability for further preclinical and clinical studies.

Biological evaluations have also revealed promising results. In vitro and in vivo studies have demonstrated the compound's efficacy in various disease models, including inflammatory disorders and certain types of cancer. Its pharmacokinetic profile, including absorption, distribution, metabolism, and excretion (ADME), is currently under investigation to assess its suitability as a drug candidate. Early data indicate favorable bioavailability and low toxicity, which are encouraging for future development.

Despite these advancements, challenges remain. The precise mechanism of action of N-(4-Amino-5-chloro-2-hydroxyphenyl)-3,4-dichlorobenzamide is not yet fully understood, and further mechanistic studies are required. Additionally, its potential off-target effects and long-term safety profile need to be thoroughly evaluated. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the resolution of these issues.

In conclusion, N-(4-Amino-5-chloro-2-hydroxyphenyl)-3,4-dichlorobenzamide (CAS: 95709-82-3) represents a promising candidate for further investigation in the field of chemical biology and drug development. Its unique structural properties and biological activities make it a valuable subject of study, with potential applications in treating a range of diseases. Continued research and development efforts will be essential to fully realize its therapeutic potential.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)